Outlook Therapeutics (OTLK) Preferred Shares (2016 - 2018)

Outlook Therapeutics (OTLK) reported Preferred Shares of $2.7 million for Q1 2018, little changed quarter-over-quarter from $2.7 million in Q4 2017.

Outlook Therapeutics (OTLK) Preferred Shares (2016 - 2018) Analysis & Trends

Outlook Therapeutics (OTLK) has 3 years of Preferred Shares data on file, last reported at $2.7 million in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Outlook Therapeutics	51.56 Mn	43.81 Mn	-21,888.00	-

Download Data